Byong Duk Ye

Professor

University of Ulsan College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Byong Duk Ye is a Professor at the University of Ulsan College of Medicine in South Korea. His research interests include inflammatory bowel disease, particularly focusing on ulcerative colitis and Crohn's disease, as well as the implications of biologic treatments and novel therapeutic strategies. His recent publications cover topics such as the effectiveness of app-based interventions and the clinical characteristics of patients diagnosed via advanced imaging techniques.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (32)

Kyeong Ok Kim

Professor

Yeungnam University School of Medicine and College of Medicine

SOUTH KOREA

Byong Duk Ye

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

The ‘totality of evidence’ and ‘extrapolation’ of SB17, a ustekinumab biosimilar

Risk of Spondyloarthritis in Patients With Inflammatory Bowel Disease Receiving Treatment With Biologics or Janus Kinase Inhibitors

Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis

Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial

Artificial Intelligence Models May Aid in Predicting Lymph Node Metastasis in Patients with T1 Colorectal Cancer

Guselkumab in East Asians With Moderate‐to‐Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies

Welcome to the Teal Journal: A New Look, A Greater Vision

Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study

Anti–Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women With Inflammatory Bowel Disease

Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients

Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study

Clinical characteristics and long-term disease course in patients with Crohn’s disease as diagnosed by video capsule endoscopy: a multicenter retrospective matched case-control study

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure

Burden of Herpes Zoster in Individuals with Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study

Development and Assessment of a Novel Ulcerative Colitis–Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional Study

Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease

Editorial: Another brick in the CDST wall: Authors' reply

Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial

Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

Clinical features of enteric and colo-duodenal fistula in patients with Crohn’s disease

Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease

Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab

Influence of endoscopists' expertise level on clinical outcomes after bridge‐to‐surgery stenting in obstructive colorectal cancer

Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?

Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy

Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study

Collaborators (32)

Kyeong Ok Kim

Kang-Moon Lee

Kyuwon Kim

Luis Puig

Yong Sik Yoon

Jae Hee Cheon

Dong-Hyeon Kim

Masayuki Saruta

Sung Wook Hwang

Rupert Leong

Won Suk Choi

Dong Soo Han

Hyun-Soo Kim

J. R. Fraser Cummings

DONG HYUN KIM

Sung Hoon Jung

Joo Sung Kim

Chang Sik Yu

Alessandro Armuzzi

SUNG NOH HONG

Chang Soo Eun

Hyun-Soo Zhang

Sang Hyoung Park

Dong-Hoon Yang

Chung Mo Nam

Jong Pil Im

Stefan Schreiber

Yong-Gil Kim

Dong Il Park

HONG SUB LEE

Sang-Bum Kang

Seong-Joon Koh

Make your next move.